The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a five-year period of performance through May 2025.
Under this IDC, the FDA has issued multiple delivery order contracts to Iqvia, including a $15.5 million order for outpatient prescription and patient-level drug utilization data, and a $19.1 million IDIQ contract for similar data services. These data and analytics products and services support the FDA's disease control, public health, drug safety surveillance, and regulatory decision-making efforts. The contracts do not have any set-aside designations, reflecting Iqvia's position as an established provider of healthcare data and analytics to federal agencies. The place of performance for Iqvia's work is in Silver Spring, Maryland.
Generated 9/7/24, 10:34 AM